Observational Study
Copyright ©The Author(s) 2022.
World J Nephrol. Jul 25, 2022; 11(4): 127-138
Published online Jul 25, 2022. doi: 10.5527/wjn.v11.i4.127
Table 2 Demographic and clinical characteristics of study participants
Characteristic

Statistic
Age (yr)Median (IQR)45 (20.5)
SexMale, n (%)46 (57.5)
CKD duration (mo)Median (IQR)12.5 (24.5)
Dialysis vintageMedian (IQR)9 (15)
Blood pressure (mmHg)Systolic mean ± SD150 ± 31
Diastolic mean ± SD91 ± 19
Body mass index (kg/m2)Median (IQR)21.94 (5.13)
ComorbiditiesHypertension, n (%)41 (51.25)
Glomerulonephritis, n (%)22 (27.5)
Diabetes mellitus, n (%)14 (17.5)
Obstructive uropathy, n (%)8 (10)
HIV, n (%)7 (8.75)
Malignancy, n (%)2 (2.5)
Graft failure post-transplant, n (%)2 (2.5)
Cystic kidney disease, n (%)1 (1.25)
Dialysis access Arterio-venous fistula, n (%)26 (32.5)
Clinical scoreHypovolemia, n (%)0 (0.00)
Normovolemia, n (%)33 (41.25)
Hypervolemia, n (%)47 (58.25)
BIADehydration, n (%)0 (0.00)
Normal hydration, n (%)9 (11.25)
Fluid overload, n (%)71 (88.75)
Mild FO, n (%)25 (31.25)
Gross FO, n (%)46 (57.50)